Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Incannex Healthcare Inc. (IXHL : NSDQ)

• Company Description    Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $0.22 Daily Weekly Monthly 20 Day Moving Average: 23,966,656 shares Shares Outstanding: 29.43 (millions) Market Capitalization: $6.62 (millions) Beta: 7.47 52 Week High: $3.12 52 Week Low: $0.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.68% -7.29% 12 Week -62.51% -68.46% Year To Date -89.39% -90.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Suite 105 8 Century Circuit - Norwest,NS 2153 AUS ph: 61-4-0984-0786 fax: - investors@incannex.com http://www.incannex.com

• General Corporate Information    Officers Joel Latham - Chief Executive Officer and President Troy Valentine - Chairman Joseph Swan - Chief Financial Officer Peter Widdows - Director George Anastassov - Director Peer Information Incannex Healthcare Inc. (GSAC) Incannex Healthcare Inc. (CASI) Incannex Healthcare Inc. (ALCD.) Incannex Healthcare Inc. (OMNN) Incannex Healthcare Inc. (CGPI.) Incannex Healthcare Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 45333F109 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/25 Next Expected EPS Date: 09/29/25 Share - Related Items Shares Outstanding: 29.43 Most Recent Split Date: (:1) Beta: 7.47 Market Capitalization: $6.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.39 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.56 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/29/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.54 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 36.84% vs. Previous Quarter: 27.27% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -83.78% ROE 06/30/25 - - 03/31/25 - -342.92 12/31/24 - -289.30 ROA 06/30/25 - - 03/31/25 - -148.64 12/31/24 - -154.96 Current Ratio 06/30/25 - - 03/31/25 - 2.12 12/31/24 - 1.80 Quick Ratio 06/30/25 - - 03/31/25 - 2.12 12/31/24 - 1.80 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - -22,156.12 12/31/24 - -24,261.22 Book Value 06/30/25 - - 03/31/25 - 0.42 12/31/24 - 0.05 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 2.47 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 71.19

Powered by Zacks Investment Research ©